http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2848151-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7b9a49737980e25e980bd676bd5f9c1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008
filingDate 2012-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_140cc4be25c77dec9da45f3aa5026dba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ac0cd47aafda06c61218dd36233bd8f
publicationDate 2013-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2848151-A1
titleOfInvention Device for treating eye conditions
abstract Architectures and techniques for treating conditions of the eye, such as meibomian gland disease, utilize sources of treatment energy, such as electromagnetic energy emitting devices, to implement manipulations on tissue surrounding the orbit. According to these devices and methods, the sources of treatment energy are activated to direct energy onto parts of the eye, such as the meibomian gland, to treat meibomian gland disease. The treatments can affect at least one property of the eye and allow the liquifactions to flow more freely.
priorityDate 2011-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425165937
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130922
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID53175
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577455
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23980
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1

Total number of triples: 44.